PK Study of Melphalan HCL & Alkeran for Injection of MA Conditioning in MM Patients of Autologous Transplantation
Condition(s):Multiple MyelomaLast Updated:December 17, 2019Completed
Hide Studies Not Open or Pending
Condition(s):Multiple MyelomaLast Updated:December 17, 2019Completed
Condition(s):Metastatic Ocular Melanoma; Metastatic Uveal MelanomaLast Updated:December 21, 2023Active, not recruiting
Condition(s):Multiple MyelomaLast Updated:January 10, 2023Recruiting
Condition(s):Multiple MyelomaLast Updated:October 10, 2018Completed
Condition(s):RetinoblastomaLast Updated:August 2, 2016Terminated
Condition(s):Multiple MyelomaLast Updated:August 5, 2021Completed
Condition(s):Multiple MyelomaLast Updated:August 27, 2020Unknown status
Condition(s):LeukemiaLast Updated:December 11, 2023Active, not recruiting
Condition(s):Cancer, Appendiceal; ColoRectal CancerLast Updated:June 9, 2023Recruiting
Condition(s):Hematopoietic Cell Transplantation Recipient; Recurrent Plasma Cell Myeloma; Refractory Plasma Cell MyelomaLast Updated:February 21, 2020Withdrawn
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.